Clinical Scorecard: The Role of High-Sensitivity C-Reactive Protein in Age-Related Vascular Dysfunction: Insights from the Rotterdam Study
At a Glance
Category
Detail
Condition
Age-related vascular dysfunction including arterial stiffness and intima-media thickening
Key Mechanisms
Chronic low-grade systemic inflammation indexed by high-sensitivity C-reactive protein (hsCRP) and lipid metabolism
Target Population
Middle-aged and elderly individuals (aged 45 and older) from the Rotterdam Study cohort
Care Setting
Population-based clinical research and cardiovascular risk assessment settings
Key Highlights
hsCRP significantly mediates the effect of age on carotid intima-media thickness (cIMT) and pulse wave velocity (PWV), markers of vascular dysfunction.
Mediation effects of hsCRP on vascular ageing are comparable to those of lipid markers and are stronger in men than women.
Mendelian randomization analyses support a potential causal role of hsCRP in arterial stiffness (PWV) but not in structural thickening (cIMT).
Guideline-Based Recommendations
Diagnosis
Assess vascular dysfunction using carotid intima-media thickness (cIMT) and pulse wave velocity (PWV) measurements in aging populations.
Measure high-sensitivity C-reactive protein (hsCRP) as a biomarker of chronic low-grade systemic inflammation.
Management
Consider anti-inflammatory strategies alongside lipid-lowering therapies to reduce cardiovascular risk associated with vascular ageing.
Tailor interventions recognizing sex-specific differences, with men potentially benefiting more from targeting inflammatory pathways.
Monitoring & Follow-up
Longitudinal monitoring of hsCRP levels and vascular function parameters (cIMT and PWV) to evaluate progression of vascular ageing.
Monitor lipid profiles concurrently to assess combined effects on vascular health.
Risks
Increased hsCRP levels indicate heightened systemic inflammation contributing to vascular stiffness and cardiovascular risk.
Sex differences in inflammatory mediation suggest differential risk profiles and therapeutic responses.
Patient & Prescribing Data
Middle-aged and elderly adults participating in the Rotterdam Study cohort
Anti-inflammatory interventions may complement lipid-lowering treatments to mitigate age-related vascular dysfunction, especially in men with elevated hsCRP.
Clinical Best Practices
Incorporate hsCRP measurement in cardiovascular risk assessment protocols for aging patients.
Use both structural (cIMT) and functional (PWV) vascular assessments to comprehensively evaluate vascular ageing.
Recognize and address sex-specific differences in inflammatory pathways when designing prevention and treatment strategies.
Employ Mendelian randomization insights to guide causal inference and therapeutic targeting of inflammation in vascular ageing.
Joint clinical consensus outlines evaluation and management considerations for arrhythmias, coronary atherosclerosis, aortic dilatation, myocardial fibrosis, and related findings in older competitive athletes.
